SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001415889-18-000924
Filing Date
2018-06-13
Accepted
2018-06-13 16:18:39
Documents
3
Period of Report
2018-06-13
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8k-06132018_010624.htm 8-K 14545
2 ex99-06132018_010629.htm EX-99 21256
3 graphic-06132018_040625.jpg GRAPHIC 10774
  Complete submission text file 0001415889-18-000924.txt   51973
Mailing Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-577-3600
VistaGen Therapeutics, Inc. (Filer) CIK: 0001411685 (see all company filings)

IRS No.: 205093315 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-37761 | Film No.: 18896908
SIC: 2834 Pharmaceutical Preparations